Benzazepines 1 and 2 (SCH 23390 and SCH 39166, respectively) are two classical benzazepine D1/D5 antagonists, with Ki values 1.4 and 1.2 nM, respectively. Compound 2 has been in human clinical trials for a variety of diseases, including schizophrenia, cocaine addition, and obesity. Both 1 and 2 displayed low plasma levels and poor oral bioavailability, due to rapid first-pass metabolism of the phenol moieties. Several heterocyclic systems containing an N-H hydrogen bond donor were synthesized and evaluated as phenol isosteres. The preference orientation of the hydrogen bond was established by comparison of analogues containing different NH vectors. Replacement of the phenol group of 2 with an indole ring generated the first potent D1/D5 antagonist 11b. Further optimization led to the synthesis of very potent benzimidazolones 19, 20 and benzothiazolone analogues 28, 29. These compounds have excellent selectivity over D2-D4 receptors, alpha2a receptor, and the 5-HT transporter. Compared to 2, these heterocyclic phenol isosteres showed much better pharmacokinetic profiles as demonstrated by rat plasma levels. In sharp contrast, similar phenolic replacements in 1 decreased the binding affinity dramatically, presumably due to a conformational change of the pendant phenyl group. However, one indazole compound 33 was identified as a potent D1/D5 ligand in this series.
Antagonists. -Analogues of the lead structure containing an urea moiety which possess isosteric amide and benzimidazole groups generate novel MCH antagonists. Structure-activity relationships on the electron-induced effects of various linkers and substituents on the phenyl rings and the piperidine nitrogen lead to the discovery of some single-digit nanomolar MCH R1 antagonists such as (I). -(WU*, W.-L.; BURNETT, D. A.; SPRING, R.; QIANG, L.; SASIKUMAR, T. K.; DOMALSKI, M. S.; GREENLEE, W. J.; O'NEILL, K.; HAWES, B. E.; Bioorg. Med. Chem. Lett. 16 (2006) 14, 3668-3673; Schering-Plough Res. Inst., Kenilworth, NJ 07033, USA; Eng.) -H. Hoennerscheid 42-135
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.